123 related articles for article (PubMed ID: 23879381)
1. Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis.
Poyraz O; Jeankumar VU; Saxena S; Schnell R; Haraldsson M; Yogeeswari P; Sriram D; Schneider G
J Med Chem; 2013 Aug; 56(16):6457-66. PubMed ID: 23879381
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening.
Jean Kumar VU; Poyraz Ö; Saxena S; Schnell R; Yogeeswari P; Schneider G; Sriram D
Bioorg Med Chem Lett; 2013 Mar; 23(5):1182-6. PubMed ID: 23391589
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into catalysis and inhibition of O-acetylserine sulfhydrylase from Mycobacterium tuberculosis. Crystal structures of the enzyme alpha-aminoacrylate intermediate and an enzyme-inhibitor complex.
Schnell R; Oehlmann W; Singh M; Schneider G
J Biol Chem; 2007 Aug; 282(32):23473-81. PubMed ID: 17567578
[TBL] [Abstract][Full Text] [Related]
5. Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis.
Brunner K; Steiner EM; Reshma RS; Sriram D; Schnell R; Schneider G
Bioorg Med Chem Lett; 2017 Oct; 27(19):4582-4587. PubMed ID: 28882483
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design of Inhibitors of the Crucial Cysteine Biosynthetic Pathway Enzyme O-Acetyl Serine Sulfhydrylase.
Mazumder M; Gourinath S
Curr Top Med Chem; 2016; 16(9):948-59. PubMed ID: 26303427
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.
Brunner K; Maric S; Reshma RS; Almqvist H; Seashore-Ludlow B; Gustavsson AL; Poyraz Ö; Yogeeswari P; Lundbäck T; Vallin M; Sriram D; Schnell R; Schneider G
J Med Chem; 2016 Jul; 59(14):6848-59. PubMed ID: 27379713
[TBL] [Abstract][Full Text] [Related]
8. Structure, mechanism, and conformational dynamics of O-acetylserine sulfhydrylase from Salmonella typhimurium: comparison of A and B isozymes.
Chattopadhyay A; Meier M; Ivaninskii S; Burkhard P; Speroni F; Campanini B; Bettati S; Mozzarelli A; Rabeh WM; Li L; Cook PF
Biochemistry; 2007 Jul; 46(28):8315-30. PubMed ID: 17583914
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
Saxena S; Devi PB; Soni V; Yogeeswari P; Sriram D
J Mol Graph Model; 2014 Feb; 47():37-43. PubMed ID: 24316937
[TBL] [Abstract][Full Text] [Related]
10. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of O-Acetylserine sulfhydralase (OASS) isoform 3 from Entamoeba histolytica: Pharmacophore-based virtual screening and validation of novel inhibitors.
Dharavath S; Vijayan R; Kumari K; Tomar P; Gourinath S
Eur J Med Chem; 2020 Apr; 192():112157. PubMed ID: 32145643
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of N(alpha)-acetyl-L-ornithine deacetylase: synthesis, characterization and analysis of their inhibitory potency.
Hlavácek J; Pícha J; Vanek V; Jirácek J; Slaninová J; Fucík V; Budĕsínský M; Gilner D; Holz RC
Amino Acids; 2010 Apr; 38(4):1155-64. PubMed ID: 19649769
[TBL] [Abstract][Full Text] [Related]
13. Refining the structure-activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms.
Magalhães J; Franko N; Annunziato G; Pieroni M; Benoni R; Nikitjuka A; Mozzarelli A; Bettati S; Karawajczyk A; Jirgensons A; Campanini B; Costantino G
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):31-43. PubMed ID: 30362368
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors.
Zheng X; Bauer P; Baumeister T; Buckmelter AJ; Caligiuri M; Clodfelter KH; Han B; Ho YC; Kley N; Lin J; Reynolds DJ; Sharma G; Smith CC; Wang Z; Dragovich PS; Gunzner-Toste J; Liederer BM; Ly J; O'Brien T; Oh A; Wang L; Wang W; Xiao Y; Zak M; Zhao G; Yuen PW; Bair KW
J Med Chem; 2013 Aug; 56(16):6413-33. PubMed ID: 23859118
[TBL] [Abstract][Full Text] [Related]
15. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
[TBL] [Abstract][Full Text] [Related]
16. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
17. Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.
Naik M; Raichurkar A; Bandodkar BS; Varun BV; Bhat S; Kalkhambkar R; Murugan K; Menon R; Bhat J; Paul B; Iyer H; Hussein S; Tucker JA; Vogtherr M; Embrey KJ; McMiken H; Prasad S; Gill A; Ugarkar BG; Venkatraman J; Read J; Panda M
J Med Chem; 2015 Jan; 58(2):753-66. PubMed ID: 25486447
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
19. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
[TBL] [Abstract][Full Text] [Related]
20. Structural enzymology of sulphur metabolism in Mycobacterium tuberculosis.
Schnell R; Schneider G
Biochem Biophys Res Commun; 2010 May; 396(1):33-8. PubMed ID: 20494107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
